Andrea Veronesi

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

Luca Gianni, Urania Dafni, Richard D. Gelber et al. · The Lancet Oncology · 2011 · 611 citations

Breast Oncology, Oncology, Adjuvant Chemotherapy +5

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Diana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch et al. · Journal of Clinical Oncology · 2000 · 294 citations

Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features

Maria Antonietta Pizzichetta, Renato Talamini, Ignazio Stanganelli et al. · British Journal of Dermatology · 2004 · 233 citations

Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding

Barbara Belletti, Jayant S. Vaidya, Sara D’Andrea et al. · Clinical Cancer Research · 2008 · 230 citations

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Diana Crivellari, Olivia Pagani, Andrea Veronesi et al. · Annals of Oncology · 2001 · 150 citations · Full text

Neuro-oncology, Advanced Breast Cancer, Breast Oncology +7